Skip to main content
. 2024 Jun 26;16(13):2023. doi: 10.3390/nu16132023

Table 3.

Side effects observed during the study *.

Side Effect AI-Guided Group (n = 34) Physician-Guided Group (n = 33) p-Value
Gastrointestinal symptoms (mild nausea, diarrhea) 5 (14.7%) 4 (12.1%) p = 0.76
Headaches 3 (8.8%) 3 (9.1%) p = 0.95
Muscle pain 2 (5.9%) 2 (6.1%) p = 0.98
Serious adverse events 0 (0%) 0 (0%) -

* Data are expressed as the mean percent change from baseline (95% confidence interval). Changes from baseline at each time point were analyzed using repeated measures ANOVA, incorporating baseline values and subsequent measurements at 1, 2, and 3 months. Post-hoc comparisons were adjusted using the Bonferroni correction to control for multiple comparisons. Abbreviations: LDL-C, low-density lipoprotein cholesterol; TG, triglycerides.